Diabetic nephropathy

被引:0
|
作者
Menne, J. [1 ]
Haller, H. [1 ]
机构
[1] Hannover Med Sch, D-30625 Hannover, Germany
来源
INTERNIST | 2011年 / 52卷 / 05期
关键词
Albuminuria; Hypertension; HbA(1c); Renin angiotensin system; Diabetic nephropathy; STRUCTURAL-FUNCTIONAL RELATIONSHIPS; CARDIOVASCULAR EVENTS; RENAL-DISEASE; MICROALBUMINURIA; INTERVENTION; METAANALYSIS; ALBUMINURIA; PROTEINURIA; PREVENTION; MORTALITY;
D O I
10.1007/s00108-010-2761-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is the most common cause of end-stage renal disease. Since the disease progresses very slowly and usually takes more than 20 years before terminal renal failure occurs, early intervention is of great importance in order to prevent this disabling complication. A good control of diabetes with HbA(1c) levels around 7% is desirable. At least as important is the treatment of elevated blood pressure values. The target value for patients with diabetes has been adjusted in the last year and is now 130-139/80-85 mmHg. Should (micro-)albuminuria or renal insufficiency be present the blood pressure target is < 130/80 mmHg. For the control of hypertension the use of ACE inhibitors or angiotensin receptor blockers is recommended. In addition, the control of other risk factors and appropriate therapeutic intervention is required. A multifactorial intervention leads to the best results and can avoid the occurrence or progression of diabetic kidney disease and other micro- and/or macrovascular complications.
引用
收藏
页码:495 / +
页数:8
相关论文
共 50 条
  • [21] Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
    Schjoedt, K. J.
    Rossing, K.
    Juhl, T. R.
    Boomsma, F.
    Tarnow, L.
    Rossing, P.
    Parving, H-H
    KIDNEY INTERNATIONAL, 2006, 70 (03) : 536 - 542
  • [22] A Study of Association of Urinary Nephrin with Albuminuria in Patients with Diabetic Nephropathy
    Kondapi, Kishore
    Kumar, N. Lakshmana
    Moorthy, Swathi
    Silambanan, Santhi
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (02) : 142 - 148
  • [23] Assessment of urinary γ-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy
    De Carvalho, Jose A. M.
    Piva, Silvia J.
    Hausen, Bruna S.
    Bochi, Guilherme V.
    Kaefer, Michelle
    Coelho, Adriane C.
    Duarte, Marta M. M. F.
    Moresco, Rafael N.
    CLINICA CHIMICA ACTA, 2011, 412 (15-16) : 1407 - 1411
  • [24] Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy
    Andersen, Henrik
    Hansen, Pernille B. L.
    Bistrup, Claus
    Nielsen, Flemming
    Henriksen, Jan Erik
    Jensen, Boye L.
    JOURNAL OF HYPERTENSION, 2016, 34 (08) : 1621 - 1629
  • [25] Diabetic nephropathy
    Wylie, Emma C.
    Satchell, Simon C.
    CLINICAL MEDICINE, 2012, 12 (05) : 480 - 482
  • [26] Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study
    Okamura, Takuro
    Ushigome, Emi
    Kitagawa, Nobuko
    Oyabu, Chikako
    Tanaka, Toru
    Hasegawa, Goji
    Nakamura, Naoto
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Ushigome, Hidetaka
    Yokota, Isao
    Hamaguchi, Masahide
    Asano, Mai
    Yamazaki, Masahiro
    Fukui, Michiaki
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (06) : 1543 - 1549
  • [27] Diabetic nephropathy
    Ibrahim, HAA
    Vora, JP
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 13 (02) : 239 - 264
  • [28] Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
    Sattarinezhad, A.
    Roozbeh, J.
    Yeganeh, B. Shirazi
    Omrani, G. R.
    Shams, M.
    DIABETES & METABOLISM, 2019, 45 (01) : 53 - 59
  • [29] Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomised controlled trial
    Koya, D.
    Haneda, M.
    Inomata, S.
    Suzuki, Y.
    Suzuki, D.
    Makino, H.
    Shikata, K.
    Murakami, Y.
    Tomino, Y.
    Yamada, K.
    Araki, S. I.
    Kashiwagi, A.
    Kikkawa, R.
    DIABETOLOGIA, 2009, 52 (10) : 2037 - 2045
  • [30] Diabetic nephropathy: Recent insights into the pathophysiology and the progression of diabetic nephropathy
    Gross, ML
    Dikow, R
    Ritz, E
    KIDNEY INTERNATIONAL, 2005, 67 : S50 - S53